RiboBio
瑞博生物
RiboBio
Biotech/Healthcare
RiboBio is an innovative drug developer focused on small nucleic acid therapeutics. The company has independently developed an integrated R&D platform covering the full lifecycle from early-stage research through commercialization.
Latest round: IPO (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.